Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on ACRX, SHLD, TJX and XEL Issued by the Paragon Report

TLPH, TJX, XEL
Free Research Reports on ACRX, SHLD, TJX and XEL Issued by the Paragon Report

NEW YORK, NY -- (Marketwired) -- 05/22/13 -- The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Paragon is an essential resource for hundreds of thousands of investors across the country.

AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) shares traded in the range of $6.40 to $7.42 Tuesday on volume of over 1.5 million shares traded. The company announced that its NanoTab pain treatment system achieved its primary efficacy endpoint in a recent Phase 3 study. AcelRx shares hit a new all-time high of $7.42 per share.

Find out more about AcelRx Pharmaceuticals including full access to the free equity report at: www.ParagonReport.com/ACRX

Sears Holdings Corp. (NASDAQ: SHLD) shares have gained approximately 42 percent year-to-date. The company is expected to release results for the first quarter of 2013 after market close on Thursday, May 23rd. Average analysts' estimates call for a loss of $0.60 per share for quarter, according to data from FactSet.

Find out more about Sears including full access to the free equity report at: www.ParagonReport.com/SHLD

The TJX Companies, Inc. (NYSE: TJX) shares traded in the range of $50.43 to $51.83 Tuesday after releasing quarterly earnings. The company reported net sales were $6.2 billion for the first quarter of fiscal 2014, an increase of 7 percent when compared to net sales of $5.8 billion in the year ago quarter.

Find out more about The TJX Companies including full access to the free equity report at: www.ParagonReport.com/TJX

Xcel Energy Inc. (NYSE: XEL) shares have gained approximately 13.0 percent year-to-date. The company reported earnings of $237 million, or $0.48 per share, for the first quarter of 2013, compared to earnings of $184 million, or $0.38 per share, in the year ago quarter.

Find out more about Xcel Energy including full access to the free equity report at: www.ParagonReport.com/XEL

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today